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Abstract
Background: The Notch pathway is essential for proper epidermal differentiation during embryonic skin development.
Moreover, skin specific loss of Notch signaling in the embryo results in skin barrier defects accompanied by a B-
lymphoproliferative disease. However, much less is known about the consequences of loss of Notch signaling after birth.
Methodology and Principal Findings: To study the function of Notch signaling in the skin of adult mice, we made use of a
series of conditional gene targeted mice that allow inactivation of several components of the Notch signaling pathway
specifically in the skin. We demonstrate that skin-specific inactivation of Notch1 and Notch2 simultaneously, or RBP-J,
induces the development of a severe form of atopic dermatitis (AD), characterized by acanthosis, spongiosis and
hyperkeratosis, as well as a massive dermal infiltration of eosinophils and mast cells. Likewise, patients suffering from AD,
but not psoriasis or lichen planus, have a marked reduction of Notch receptor expression in the skin. Loss of Notch in
keratinocytes induces the production of thymic stromal lymphopoietin (TSLP), a cytokine deeply implicated in the
pathogenesis of AD. The AD-like associated inflammation is accompanied by a myeloproliferative disorder (MPD)
characterized by an increase in immature myeloid populations in the bone marrow and spleen. Transplantation studies
revealed that the MPD is cell non-autonomous and caused by dramatic microenvironmental alterations. Genetic studies
demontrated that G-CSF mediates the MPD as well as changes in the bone marrow microenvironment leading to
osteopenia.
Significance: Our data demonstrate a critical role for Notch in repressing TSLP production in keratinocytes, thereby
maintaining integrity of the skin and the hematopoietic system.
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Introduction
The skin epidermis and its appendages represent a constantly
renewing physical barrier that protects against mechanical injuries,
infective organisms and excessive loss of water [1]. Cellular
processes such as proliferation, migration and cell death must be
highly regulated in order to ensure life long homeostasis. The
molecular pathways controlling these processes have only just
started to be explored. The Notch pathway plays a key role in
differentiation of the epidermis and its appendages. Notch proteins
comprise a family of four type I transmembrane receptors that
influence cell fate decision and differentiation processes in multiple
organisms and tissues [2,3]. Notch signaling is triggered upon the
binding of ligands of the Jagged and Delta family, which leads to
the proteolytic release of the intracellular cytoplasmic domain of
Notch receptors (NIC). The released NIC subsequently translo-
cates to the nucleus where it binds to the transcriptional repressor
CSL (RBP-J) to activate target gene expression [4].
Most of our current knowledge regarding Notch signaling in
skin and hair follicles is derived from both gain and loss of function
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studies in primary keratinocytes, or from genetic studies
inactivating different Notch signaling components during embry-
onic development [5,6,7,8,9,10,11,12,13]. Thus, Notch mediated
RBP-J signaling has been shown to be important for terminal
differentiation and maintenance of hair follicles and sebaceous
glands [6,7,14]. Moreover, Notch signaling was shown to be
important in the specification of the spinous layer through the
Notch target gene Hes1 and in the downregulation of the basal cell
fate of the interfollicular epidermis [5,10,12]. Skin-specific ablation
of Notch signaling during embryogenesis leads to death before
weaning, due to the loss of epidermal barrier function accompa-
nied by the development of a systemic B-lymphoproliferative
disorder (B-LPD) [13].
The role of Notch signaling in adult skin is less clear and has
only been partially investigated [5,10,14,15]. In postnatal skin,
Notch signaling is predominantly mediated through the Notch1
and Notch2 receptors [5]. Postnatal K5-CreERT mediated
inactivation of Notch1 in the skin results in hyperproliferation
with expansion of the proliferative basal cell layer, hair loss and
epidermal cyst formation within less then one month [5,14]. A
long-term consequence of Notch1 deficiency in adult skin is the
development of skin tumors, suggesting that in addition to
regulating differentiation processes in the skin, Notch signaling is
also associated with tumor suppressive functions [15,16].
Here, we show that simultaneous ablation of Notch1 and
Notch2 signaling in the adult skin results in a severe form of atopic
dermatitis-like disease as a result of highly elevated levels of TSLP.
The AD-like disease is accompanied by a cell non-autonomous G-
CSF induced myeloproliferative disorder and osteopenia, all of
which is caused by TSLPR mediated signaling.
Results
Postnatal Loss of Notch Signaling in the Skin Results in
an Atopic Dermatitis (AD)-Like Disease in the Adult
Mouse
The function of Notch signaling during skin homeostasis was
characterized using mice bearing homozygously floxed alleles for
Notch1, for Notch2, for both Notch1 and Notch2 [17], and for RBP-J
[18]. These mice were crossed to transgenic mice expressing a
tamoxifen inducible Cre-recombinase (CreERT) under the control
of the Keratin5 promoter [19] (hereafter: N1K5, N2K5, N1N2K5,
RBP-JK5). Eight day-old mutant mice and corresponding
littermate controls, lacking the CreERT transgene, were injected
with tamoxifen for 5 consecutive days and analyzed 30 to 40 days
post injection (Figure 1). Gene specific deletion efficiency was
assessed by Southern blot analysis of genomic DNA isolated from
the epidermis of the different gene targeted mice at the time point
of analysis. The recombination efficiency in N1K5 and N2K5 was
.80% (data not shown), and 70% in N1N2K5 mice for both the
Notch1 and the Notch2 genes (Figure 1C). Postnatal skin specific
inactivation of Notch1 resulted in loss of skin appendages,
deregulation of several epidermal differentiation markers and
hyperproliferation (Figure S1) as previously reported [5]. In
contrast, postnatal skin-specific loss of Notch2 did not lead to any
apparent phenotype (Figure S1), which is similar to data describing
embryonic inactivation of Notch2 [7]. This suggests that either
Notch2 has no function in murine skin, or that its loss is fully
compensated by redundant Notch1 signaling. This question was
addressed by analyzing mice with simultaneous inactivation of
both Notch1 and Notch2 in the epidermis. Moreover, the
phenotype of these mice was compared to mice in which RBP-J,
the downstream mediator for all Notch receptors, was inactivated.
N1N2K5 mice start to lose hair as soon as 1 week post
tamoxifen injection and show complete and irreversible hair loss
after 1 month (Figure 1A). Interestingly, mice with skin specific
inactivation of both Notch1 and Notch2 receptors, or RBP-J, but
not of individual receptors, became moribund and died with 100%
penetrance within 7 weeks of tamoxifen injection (Figure 1B and
data not shown).
Histological analysis of Notch mutant mice revealed a massive
dermal hypercellularity, a complete loss of subcutaneous fat, the
presence of numerous hyperproliferative epidermoid cysts in the
dermis and a thickened and hyperkeratinized epidermis (acantho-
sis and hyperkeratosis) (Figure 1D, E and Figure S1) in mutant skin
sections of N1N2K5 and RBP-JK5, but not of N1K5 or N2K5
mice. In addition, the epidermis of N1N2K5 (Figure 1D, E) and
RBP-JK5 (data not shown) mice showed signs of intercellular
oedema (epidermal spongiosis). The underlying dermis exhibited
inflammatory infiltrates, mostly characterized by eosinophils, the
accumulation of mast cells, and dilated blood vessels (Figure 1D,
F). Moreover, flow cytometric analysis of dermis derived CD45+
cells revealed an increase in the percentage of these cells as well as
in inflammatory (CD11c+CD11b+Ly6C+) dendritic cells (DC)
[20], CD103+ Langerin+ DC [21], T and B cells as well as
neutrophiles in N1N2K5 mice as compared to control animals
(Figure S2). Quantitative real-time PCR for T helper specific
cytokines using dermis-derived RNA revealed increased IL-4 and
IL-13 mRNA levels in Notch mutant mice, whereas mRNA levels
for IFNc, IL-12, IL-17a, IL-21 and IL-22 where not significantly
altered, indicating an infiltration of Th2 cells (Figure 1G, and
Figure S3). Interestingly, we also found high serum IgE levels in
the Notch mutant mice (Figure 1H). Taken together, these results
suggest that loss of Notch signaling in the epidermis of adult mice
induces a strong inflammatory response with many hallmarks of
Atopic Dermatitis (AD; referred hereafter as AD-like disease).
TSLP Induces an AD-Like Disease Due to Loss of Notch
Signaling in the Skin
Consequently, we investigated more specifically the strong
inflammatory response within the Notch deficient epidermis. For
this purpose, we selectively isolated RNA from the epidermis of
control, N1N2K5 and RBP-JK5 mice and conducted quantitative
real-time PCR analysis for a panel of inflammatory cytokines,
many of which were significantly increased (Figure 2A). These
included TNFa (2.5 fold), IL-1b (28 fold) and IL-6 (27 fold), MCP1
(15 fold), MIP3a (43 fold), S100A8 (15 fold), S100A9 (56 fold), G-
CSF (6 fold) and ICAM1 (3.5 fold). However, the cytokine TSLP
showed the highest increase in relative amount (up to 125 fold), in
both N1N2 and RBP-J deficient epidermis. Other Keratin 5-
expressing tissues such as the thymic epithelium or bone marrow
(BM) cells did not show increased TSLP expression (data not
shown). Protein levels of TNFa and IL-1b were similar throughout
the serum samples of mice investigated (data not shown).
However, TSLP levels increased 400 fold in N1N2K5 and RBP-
JK5 mice. They reached on average 4 to 7 ng/ml respectively
(Figure 2B), suggesting that TSLP might be causative for the AD-
like phenotype, as previously reported in humans and mice
[22,23,24].
It seemed essential to exclude the possibility that the observed
phenotypes may be caused by ectopic expression of the Cre
recombinase in an organ other than the skin. Thus, we
transplanted the skin of control and N1N2K5 newborn pups onto
athymic nu/nu mice. Two months post-transplantation, the grafted
mice were injected with tamoxifen in order to simultaneously
inactivate both Notch receptors within the skin transplants.
Histological analysis of the skin grafts derived from N1N2K5
Notch, Atopic Dermatitis & MPD
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Figure 1. Loss of Notch signaling in post-natal epidermis leads to a severe form of atopic dermatitis and lethality. (A) Representative
photograph of Control (Ctrl) and N1N2K5 mice 38 days post first injection of tamoxifen showing loss of hair, thick, dry, and scaly skin. (B) Survival
curve of control (Ctrl, n = 20) and N1N2K5 (n = 24) mice after tamoxifen injection. The survival curve is the combined result of 3 individual
experiments. (C) Southern blot analysis of genomic DNA from scraped epidermis from control (Ctrl, n = 2) and N1N2K5 mice (n = 3) showing the
floxed and the recombined (Recomb) alleles of Notch1 and Notch2 respectively. The recombination efficiency is .70% for both genes. Three
individual experiments were performed. (D) Representative HE staining on control (Ctrl) and N1N2K5 dorsal skin sections showing a thickened
epidermal layer (e) a massively infiltrated dermis (d) with large epidermoid cysts (c) from degenerated hair follicles (hf) and absence of subcutis (sc)
above the muscles (m). Asterisks indicate enlarged regions of the skin showing acanthosis, hyperkeratosis and spongiosis of the epidermis as well as
eosinophil infiltrates (arrows) around dilated blood vessels (bv) in the dermis (n = 8, 4 individual experiments were performed). (E) Goldner’s
Trichrome (GT) readily shows the spongiosis and hyperkeratosis (n = 7, 4 individual experiments were performed). (F) Toluidine blue (TB) staining on
control (Ctrl) and N1N2K5 skin sections showing massive infiltration of mast cells (dark blue) (n = 7, 4 individual experiments were performed). (G)
Quantitative RT-PCR on dermis-derived RNA for the T helper specific cytokine IL-4 from Ctrl and N1N2K5 mice. The experiment was performed in
triplicates (n = 3 per sample group, two individual experiments were performed). (H) A 16-fold increase in serum IgE levels is observed in N1N2K5
compared to Ctrl mice. The experiment was performed in triplicates (n = 3 per sample group, three individual experiments). (* p,0.01; ** p,0.001).
[Scale bars: 50 mm].
doi:10.1371/journal.pone.0009258.g001
Notch, Atopic Dermatitis & MPD
PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9258
mice, but not from control mice, showed a thickened and
hyperkeratinized epidermis, epidermoid cysts and dermal inflam-
matory infiltrates characterized by the recruitment of mast cells
(Figure 2C, D). In addition, sera of nude mice transplanted with
N1N2K5 skin showed a 13-fold increase in TSLP protein levels
compared to control sera (Figure 2E). These results strongly
suggest that the AD-like phenotype is indeed a consequence of the
specific loss of Notch signaling in the epidermis.
To investigate whether TSLP expression in the skin is sufficient
to cause AD, transgenic mice expressing TSLP under the Keratin14
promoter (K14-TSLP) were compared to the Notch deficient
animals. K14-TSLP mice exhibit a nearly identical skin phenotype
to Notch signaling deficient mice, showing hyperproliferation,
acanthosis, spongiosis and hyperkeratosis, as well as mast cell
infiltration in the dermis, but normal hair follicles (Figure S4).
Together, these data indicate that TSLP in this setting is sufficient
to cause AD in mice, which is consistent with a previous report
[23].
Notch Receptors Are Downregulated in the Skin of AD
Patients
Since loss of Notch signaling and TSLP expression are linked in
mouse skin, we assessed a possible role for Notch in the etiology of
AD in humans. Therefore, we analyzed the presence of Notch
Figure 2. Notch signaling deficient epidermis massively produces TSLP. (A) qRT-PCR analysis of inflammatory cytokines on scraped
epidermis of control (Ctrl, n = 3), N1N2K5 (n = 3) and RBP-JK5 (n = 3) mice (* p,0.01; ** p,0.001) showing relative increased expression of a wide
panel of cytokines in mutant mice. TSLP shows the highest relative increase (125 fold) in mRNA among the tested cytokines. Three individual
experiments were performed. (B) Serum TSLP levels in control (Ctrl, n = 4), N1N2K5 (n = 4) and RBP-JK5 (n = 4) mice revealing a 400 fold increase of
this cytokine in mutant mice. The experiment was performed in triplicates. (C-D) Control (Ctrl) and N1N2K5 new born skin was grafted onto Athymic
nu/nu mice and allowed to grow for 2 months (-Tamoxifen, n = 3). After induction of Cre-mediated recombination (+Tamoxifen, n = 3), the graft
develops a similar phenotype to N1N2K5 mice. H/E and Toluidin blue staining shows acanthosis, hyperkeratosis, spongiosis, epidermoid cysts and
massive infiltration of mast cells in the dermis of the N1N2K5 derived graft. Three individual experiments were performed. (E) TSLP serum levels of
athymic nu/nu mice after grafting the skin of control (Ctrl) or N1N2K5 mice and subsequent gene inactivation. Serum from 3 Ctrl and 3 grafted
Athymic nu/nu mice were pooled for the analysis. Bars represent the mean of two individual experiments.
doi:10.1371/journal.pone.0009258.g002
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receptors with a tagged ligand (DL4-FC) [17] that recognizes
presumably all four Notch paralogs in affected areas of biopsy
samples from AD patients (n = 9) compared to control patients
(n = 9). Notch receptor expression is confined to the suprabasal cell
layer of unaffected skin samples (Figure 3A-C). In contrast, Notch
receptor protein expression was greatly reduced or even no longer
detectable in lesional skin in 7 out of 9 AD patients (Figure 3D-F).
As Notch has been shown to induce early differentiation events
and has been linked to cell cycle withdrawal, it is possible that
diminished Notch receptor expression is common to many
hyperproliferative skin disorders rather then specific to AD. We
therefore analyzed biopsy samples from psoriasis (n = 4) and lichen
planus patients (n = 4). Patient tissue samples from both of these
hyperproliferative skin disorders showed a strong presence of
Notch receptors (Figure 3G-L) indicating that Notch receptor
regulation and signaling is closely linked to AD and not to the
other skin disorders tested.
Epidermal-Specific Loss of Notch Signaling Provokes a
Microenvironment-Induced Myeloproliferative Disorder
(MPD)
Despite the fact that decreased Notch receptor expression is found
in both AD and squamous cell carcinoma (SCC) patients [25], AD
patients do not seem to have an increased risk of developing skin
malignancies [26]. In contrast, they have an increased probability of
developing hematopoietic malignancies and this risk seems to correlate
with the severity of AD [27,28,29]. Interestingly, autopsy of N1N2K5
and RBP-JK5 mice revealed the development of an apparent
myeloproliferative disorder (MPD), which may account for their early
death. N1N2K5 and RBP-JK5 mice developed splenomegaly, as well
as lymphadenopathy (Figure 4A). This was characterized by a 2-3 fold
increase in absolute cell numbers of splenocytes and lymph node cells
(Figure S5). Histological and immunohistochemical analysis of the
spleen revealed loss of the red and white pulp, splenic fibrosis, loss of B
cell follicles and an increase in myeloid cells (Figure 4B), as well as
Figure 3. Notch receptor expression is down regulated in skin samples of AD patients. H/E staining of representative skin sections derived
from (A) human control skin (n = 9) and lesional sites from the following human skin disorders: (D) atopic dermatitis (n = 9), (G) psoriasis (n = 4), and
(J) lichen planus (n = 4). (B, E, F, H, I, K and L) show panNotch staining using a DL4-IgG fusion protein while (C) shows control staining with a hIgG
isotype control antibody. Nuclei are counterstained with DAPI. (E-F) shows down regulation of Notch receptor expression in skin sections from two
different AD patients, while (H-I) reveals the presence of Notch expression on sections from two psoriasis patients and (K-L) from two patients
suffering from lichen planus. [Scale bars: 50 mm].
doi:10.1371/journal.pone.0009258.g003
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Figure 4. N1N2K5 mice develop a myeloproliferative disorder (MPD). (A) Representative images of spleen and lymph node of control (Ctrl)
and N1N2K5 mice showing splenomegaly and lymphadenopathy (n = 12, three individual experiments). (B) HE staining, B220 and CD11b
immunofluorescence on spleen sections showing a loss of normal splenic architecture with fibrosis, loss of follicular structures (B220+ B cells) and
increase in CD11b+ myeloid cells in N1N2K5 mice (n = 12, three individual experiments). (C) Representative HE staining on liver sections from control
and N1N2K5 mice. The liver structure with terminal hepatic venules (v) and portal tracts (T) is changed due to periportal invasion of inflammatory cells
and fibrotic reactions in Notch mutant mice (arrows and insert, n = 8, two individual experiments). (D) Representative flow cytometric analysis of
splenic myeloid and B cells showing a massive increase in myeloid cells (CD11b+Gr-1int) and loss of follicular (B220+CD23+CD21int) and marginal zone
B cells (B220+CD23lo/-CD21+) in N1N2K5 mice. (E) Representative cytometric analysis of bone marrow myeloid and B cells showing an increase in
myeloid (CD11b+Gr-1int) and a block of B cell development at the pre-pro B stage (B220+CD43+). Numbers indicate the percentage of cells in each
gate. Results are representative of n= 12 per sample group of three individual experiments. [Scale bars: 50 mm].
doi:10.1371/journal.pone.0009258.g004
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periportal inflammatory infiltrations in the liver (Figure 4C). Flow
cytometric (FC) analysis of splenocytes derived from control and
N1N2K5 mice confirmed the immunohistochemistry and showed a
dramatic increase, in relative percentages and absolute numbers, of
mature and immature granulocytes (CD11b+Gr-1+ and CD11b+Gr-
1lo/int), and a nearly complete loss of splenic follicular
(B220+CD23+CD21int) and marginal zone (B220+CD23lo/intCD21+)
B cells (Figure 4D, Figure S5). Further analysis of the BM showed
decreased absolute cellularity, revealed an accumulation of immature
granulocytes (CD11b+Gr-1lo/int) and a block in B cell development at
the (B220+CD43+) pre-pro B cell stage (Figure 4E). Cell cycle analysis
also showed increased cycling activity of the granulocytic cell
population in the spleen of N1N2K5 and RBP-JK5 mice (data not
shown). Taken together, these data strongly suggest that epidermal-
specific loss of Notch signaling results in a MPD.
As MPD may occur due to neoplastic alterations intrinsic to
hematopoietic cells, we ensured that the phenotype observed was not
due to aberrant Cre-recombinase activity in hematopoietic progen-
itors. To exclude this possibility we generated BM chimeras by
transplanting CD45.1+ wild-type BM into CD45.2+ control,
N1N2K5 or RBP-JK5mice. The reconstitution efficiency for control,
N1N2K5 and RBP-JK5 chimeras was .80% (data not shown). The
hematopoietic system of N1N2K5 (data not shown) and RBP-JK5,
but not control, BM chimeras (which are reconstituted from WT
cells) developed an identical hematopoietic phenotype to the Notch
mutant mice (Figure S6A). Reciprocal transplantation of CD45.2+
BM cells from diseased RBP-JK5 mice into CD45.1+ wild-type
recipient mice (reconstitution efficiency .80%) led to normal
hematopoietic development as expected (Figure S6B). These results
demonstrate that the MPD-like phenotype observed in N1N2K5 and
RBP-JK5 mice is caused by systemic cell non-autonomous effects due
to loss of Notch signaling in the skin. This result is similar to the cell
non-autonomous B-LPD that was observed in mice in which Notch
signaling was abrogated during embryogenesis [13].
Excessive TSLP-Mediated Signaling in Skin Specific Notch
Mutant Mice Is Causative for Both the AD- and MPD-Like
Phenotypes
We assessed whether excessive TSLP-mediated signaling is
indeed responsible for the development of both the AD-like and
MPD phenotypes. For this purpose TSLPR2/2 mice [30] were
intercrossed with N1N2K5 mice in order to generate triple mutants
(N1N2K5 TSLPR2/2). As TSLPR2/2 mice were identical to wild
typemice in our analyses, we used the former as controls. Additional
loss of TSLPR led to a markedly less proliferative epidermis, which
was also devoid of spongiosis and displayed a substantial decrease in
inflammatory dermal infiltrates compared to N1N2K5 animals
(Figure 5A). Moreover, myeloid cell counts in peripheral blood from
N1N2K5 TSLPR2/2mice were comparable to controls, while they
were increased 5-fold in N1N2K5 mice (Figure 5B). N1N2K5
TSLPR2/2 mice had normal sized spleens and lymph nodes
(Figure 5C). FC analysis of splenocytes and BM cells of the three
different genetic groups of mice showed that the absence of TSLPR
in N1N2K5 mice was sufficient to restore normal hematopoiesis.
The spleen and BM of N1N2K5 TSLPR2/2 mice revealed the
presence of normal granulocyte numbers and no block in B cell
development (Figure 5D, E). These findings clearly reveal that both
AD and the MPD are mediated by excessive TSLP levels.
TSLP-Induced MPD in Epidermal-Specific Notch Mutant
Mice Is Mediated by G-CSF
As TSLP is mostly known to influence and/or promote B cell
development [31,32,33], it is not clear how it can induce a MPD.
To determine whether TSLP functions in a direct manner to cause
the MPD in N1N2K5 mice, we investigated the influence of TSLP
on hematopoietic differentiation. WT early BM progenitors with
lymphoid and myeloid potential (EPLM: CD117+B220int/+
CD93+CD19-CD3-NK1.1-) [34] were cultured on stromal ST-2
cells in the presence of IL-7, an essential cytokine to promote B cell
development, or with increasing concentrations of recombinant
murine TSLP. BM progenitors cultured with TSLP (0.5-50 ng/
ml) showed a developmental skew towards the B cell lineage,
implying that TSLP can substitute for IL-7 and thus favors B cell
development, which is in agreement with previous reports
[31,32,33]. Even high concentrations of TSLP in the culture
medium did not lead to an expansion of myeloid cells (Figure 6A)
suggesting that TSLP cannot enhance proliferation or differenti-
ation of immature progenitors into the myeloid lineage in a cell
autonomous manner.
The increase of immature granulocytes in the spleen and BM
(Figure 4D-E) of N1N2K5 or RBP-JK5 mice phenotypically
resembles mice that have been injected with G-CSF [35].
Moreover, the mutant mice developed osteopenia with loss of
the endosteal lining (Figure S7). A similar phenotype is observed in
patients receiving G-CSF therapy, who often suffer from
osteoporosis as a side effect [36]. This prompted us to investigate
whether G-CSF might be responsible for the myeloid hyperpro-
liferation. We first assessed G-CSF levels in sera of control,
N1N2K5 and RBP-JK5 mice. Both Notch mutant mice showed a
significant increase in G-CSF serum levels compared to control
animals (Figure 6D and data not shown). In contrast, GM-CSF
protein levels, another myeloid-promoting cytokine, were un-
changed (data not shown). We therefore hypothesized that
decreasing G-CSF concentration in Notch mutant mice would
rescue the hematopoietic phenotype. For this purpose we
intercrossed RBP-JK5 mice with G-CSF-/- mice to generate
RBP-JK5/G-CSF+/2 mice. RBP-JK5/G-CSF+/2 had serum
levels of G-CSF similar to control mice (Figure 6D). Strikingly,
the size as well as the histology of spleens derived from RBP-JK5/
G-CSF+/2 mice was comparable to control animals, while RBP-
JK5 mice showed clear splenomegaly with loss of the white and
red pulp (Figure 6C). Furthermore, FC analysis of RBP-JK5/G-
CSF+/2 mice showed a complete rescue of the hematopoietic
phenotype characterized by a normal B cell and myeloid pattern
in the BM and spleen (Figure 6E and 6F). Importantly, the
deletion efficiency of the RBP-J gene in RBP-JK5 and RBP-JK5/
G-CSF+/2 mice was comparable, suggesting that the rescue of the
hematopoietic phenotype was not simply the consequence of
unequal Cre-mediated recombination efficiency (Figure 6B).
Moreover, analysis of bone sections revealed an intact endosteal
lining (Figure S7), suggesting that G-CSF may modulate bone
homeostasis through osteoblasts. Histological analysis of the skin of
control, RBP-JK5 and RBP-JK5/G-CSF+/2 mice showed the
development of an AD-like disease in both mutant mice, implying
that reduced G-CSF serum levels did not ameliorate the skin
phenotype (Figure 6C), which is expected as TSLP serum levels
are still elevated in the RBPJ-K5/G-CSF+/2 mice (Figure 6D).
However, the median survival of RBP-JK5/G-CSF+/2 com-
pared to RBP-JK5 mice doubled (105 versus 52 days, n = 14),
suggesting that the primary cause of death of Notch mutant mice is
the G-CSF-induced MPD and not the skin disorder.
Discussion
N1N2K5 and RBP-JK5, (but not N1K5 or N2K5) mice show
clinical, histological and cellular features that are typical of human
AD. AD is the most common childhood skin disorder [37],
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disappearing in most cases with age. However, in some patients
the disease persists with severe clinical consequences. The cause of
AD is currently unknown, but its pathology has been linked to the
production of inflammatory cytokines including TNF-a, IL-1b, IL-
4, IL-5 and others [38,39]. Analysis of Notch mutant skin revealed
an increased expression of multiple inflammatory cytokines and
dermal infiltration of Th2 cells. However, secretion of the Th17
cytokines Il-21 and IL-22 that have previously been linked to
epidermal hyperplasia [40,41] was not affected. IL-17 expression is
increased in the skin of acute AD patients [42,43], while it seems to
be decreased in chronic AD patients [44,45]. In vitro, stimulation of
mouse CD4+ T cells under Th2 conditions has been shown to
abolish IL-17 and IL-22 production [40]. Thus, it is possible that
the onset of a Th2 response in the Notch mutant skin may block the
Th17 immune response.
TSLP was the cytokine found to be most dramatically increased
in both N1N2K5 and RBP-JK5 mutant mice. TSLP is an IL-7-like
cytokine and is able to support B cell differentiation and T cell
proliferation [46,47], with an ability to act on both CD4+ and
CD8+ T cells [48,49] as well as on DC [50]. Subsequent studies
showed that TSLP expression is highly upregulated in keratino-
cytes of AD patients [22] and it is also involved in allergic airway
inflammation [51,52]. It is associated with the activation of DC in
the skin causing the production of Th2 cell attracting chemokines
Figure 5. TSLP is causative of both AD and MPD in N1N2K5 mice. TSLPR2/2 mice were indistinguishable from wild type mice and therefore
only the results of TSLPR2/2 mice are shown. (A) Representative skin sections of TSLPR2/2, N1N2K5 and N1N2K5 TSLPR2/2 mice stained for HE
(upper panels), Ki67 (middle panels) and Toluidin blue (lower panels). Notch mutant mice lacking TSLPR have a markedly less proliferative epidermis,
do not develop spongiosis and have large a reduction in dermal inflammatory cells (arrows, n = 6 per sample group, three individual experiments). (B)
Myeloid cell counts in peripheral blood, and (C) spleen and lymph node (LN) macroscopy from TSLPR2/2, N1N2K5 and N1N2K5TSLPR2/2 mice
showing a rescue of the MPD phenotype. The bar diagrams represent mean values 6 SD (n = 3 for each genotype of mice, three individual
experiments). Representative flow cytometric analysis of myeloid and B cells of the spleen (D) and bone marrow (E) from TSLPR2/2, N1N2K5 and
N1N2K5 TSLPR2/2mice stained for CD11b and Gr1, CD21 and CD23 (gated on B220+ splenic B cells), or B220 and CD43 (n = 6 per sample group, three
individual experiments). [Scale bars: 50 mm].
doi:10.1371/journal.pone.0009258.g005
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[53], and activation of naı¨ve CD4 T cells which subsequently
produce inflammatory cytokines [22]. In this context, it is
interesting to note that our transplantation experiments of
N1N2K5 skin onto Athymic nu/nu mice also led to an
accumulation of dermal mast cells and the development of AD-
like features, despite the absence of functional T cells. In addition,
the small transplant was sufficient to markedly increase the TSLP
serum levels of the recipient nude mice. These findings are in
agreement with reports showing that mice overexpressing TSLP,
but lacking T or B cells (TCRb2/2, RAG2/2), also develop
allergic disorders at epithelial surfaces [23,51,54]. Activated mast
cells, which can also produce high levels of Th2 cytokines in
response to TSLP, have been identified as possible cellular
mediators of allergic disorders [54].
Postnatal inactivation of Notch signaling in murine skin leads to
hyperkeratinization of the epidermis, formation of epidermoid
cysts in the dermis, and loss of subcutaneous fat. Hyperkeratosis
could be the result of deregulated Notch-dependent control of
terminal differentiation [5]. Moreover, both loss and gain of Notch
function cause hyperkeratosis as a consequence of hair cycle
disturbance [7,14,55]. Formation of epidermal cysts is the
consequence of loss of Notch signaling within hair follicles, which
results in the activation of an epidermal differentiation program in
the outer root sheet [7]. Abnormalities in fat deposition were only
observed in the dermis, a phenotype that was previously reported
in mice with skin-specific embryonic mosaic inactivation of Notch
signaling [7]. Knowing that canonical Notch signaling is
dispensable for adipocyte specification [56], it is likely that loss
of the subcutaneous fat is a cell non-autonomous consequence of
both epidermoid cyst formation and inflammatory infiltrates.
Loss of Notch signaling in the developing epidermis of the
embryo or neonates results in a loss of epithelial barrier function
Figure 6. G-CSF is responsible for the cell non-autonomous development of the TSLP-induced MPD. (A) EPLM cultures on ST-2 cells in
presence of IL-7, or increasing concentrations of rmTSLP showing an increase in B cell numbers, but no increase of myeloid cells. The experiment was
performed twice, and each cytokine concentration was analyzed as triplicates. (B) Southern blot analysis of genomic DNA from scraped epidermis
from control (Ctrl), RBP-JK5, and RBP-JK5G-CSF+/2 mice showing the floxed and the recombined (Recomb) alleles of the RBP-J gene. Recombination
efficiency is similar for the two mutant mouse strains. Representative blot for n = 3 mice of each genotype, three individual experiments. (C) HE
staining on skin (two upper panels) and spleen (bottom panels) sections from control (Ctrl), RBP-JK5 and RBP-JK5/G-CSF+/2 mice. Macroscopy of the
spleens in inserts (n = 5 mice per sample group from two individual experiments). (D) Serum G-CSF and TSLP levels in control (Ctrl), RBP-JK5 and RBP-
JK5/G-CSF+/2 mice (* = p value,0.02). The bar diagrams represent mean values 6 SD (n = 5 per sample group of mice from two individual
experiments). Representative flow cytometric analysis of myeloid and B cells of the spleen (E) and the bone marrow (F) from control (Ctrl), RBP-JK5
and RBP-JK5/G-CSF+/2 mice stained for CD11b and Gr1, or CD21 and CD23 (gated on B220+ splenic B cells), or B220 and CD43 within the BM
compartment (n = 5 per sample group from two individual experiments). [Scale bars: 50 mm].
doi:10.1371/journal.pone.0009258.g006
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[10], which was suggested to lead to the induction of TSLP
expression [13]. In this scenario TSLP expression was suggested to
be the indirect consequence of skin barrier defects. A number of
susceptibility genes have been identified in AD patients, many of
which are expressed in the epithelium (including SPINK5 and
Filaggrin) supporting the concept that reduced barrier function,
combined with a massive inflammatory response is at the origin of
AD [57,58].
However, additional cell intrinsic mechanisms within skin
epithelial cells have recently been shown to contribute to TSLP
expression in the absence of barrier defects or microbial products
[59]. In this context it is interesting to note that all skin specific
expression markers (including LEKTI and Desmoglein – Figure
S8) are expressed at normal levels in adult Notch mutant mice
suggesting that the skin barrier is unharmed. Moreover, minor
barrier function defects, if present at all, are not the cause of death.
The Notch mutant mice rather succumb to MPD by high G-CSF
levels since lowering G-CSF concentrations in Notch mutant mice
is sufficient to drastically prolong their survival. Thus, other cell
intrinsic mechanisms must account and/or contribute to TSLP
expression in adult Notch mutant mice. Additional signaling
cascades, including retinoid X receptor (RXR) signaling and
vitamin D3 receptor (VDR) signaling, have also been linked to
TSLP-induced AD [24,60]. Postnatal skin-specific inactivation of
both RXRa and RXRb (RXRs) leads to the development of an
AD-like disease characterized by partial hair loss, Th2 inflamma-
tion, eosinophilia, elevated TSLP epidermal secretion, and high
TSLP serum levels [24]. Although all of these phenotypic
hallmarks are shared between RXRs and Notch mutant mice, they
also exhibit certain differences; for example disease progression of
the RXRs mutant mice appears to be milder, it affects primarily
ear skin and later to a lesser extent dorsal skin. Furthermore,
RXRs mutant mice do not develop a fatal MPD or osteopenia,
presumably because of the lower (10-15 x) TSLP serum levels.
Consequently RXRs mutant mice live considerably longer
compared to Notch mutant mice. So far we could not link the
loss of Notch signaling in the epidermis to changes in retinoic acid
or vitamin D signaling (data not shown).
We show that human AD patients have reduced Notch receptor
levels on the cell surface of the suprabasal epithelium and they are
known to have an increased risk to develop hematological
malignancies [27,28,29]. Thus, it is interesting to note that adult
Notch mutant mice develop a severe MPD. Hematological
malignancies are generally considered to be the consequence of
neoplastic lesions within hematopoietic cells [61,62,63]. However,
our BM transplantation experiments combined with the genetic
rescue studies using TSLPR2/2 and G-CSF+/2 mice demonstrate
that the MPD is the result of a cell non-autonomous process
caused by TSLP-induced G-CSF secretion. The G-CSF producing
cell-type is currently unknown. Therefore, our results confirm and
strongly support a new concept in which changes within the
microenvironment can lead to the induction of MPD or other
hematological malignancies [13,64,65].
TSLP being responsible for the development of the MPD was
unexpected. Most reports involve TSLP in B cell homeostasis and/
or B cell development, together with its implication in the
development of allergic diseases. TSLP was originally described as
a cytokine, which leads to increased B cell differentiation when
added to BM B cell progenitors [31,32,46]. The main TSLP
responsive B cell target seems to be a late pro B cell
(B220+CD43+BP1+CD24+) [66], which in response to TSLP
shows increased cell cycle progression [33]. Fetal B cell progenitors
seem to be even more responsive to TSLP compared to adult B
cell progenitors [66]. This may also explain why high TSLP levels
in fetal or neonatal Notch mutant mice cause a B-LPD [13], while
the effect on B cells in adult mice is less dramatic. Interestingly,
loss of the IL-7Ra or the TSLPR chain, both of which compose
the heterodimeric TSLP receptor, rescues both the B-LPD and to
a large extent the MPD in mice in which the RBP-J or the
presenilin genes were inactivated during embryogenesis (Figure
S9). Although most studies indicate that TSLP influences the
development and homeostasis of B cells, it has also been reported
to have growth promoting functions for myeloid cells. In
particular, transgenic overexpression of TSLP using the actin
promoter [67] or the myeloid-specific Fes promoter (unpublished
observations [33]) resulted in mice with myeloid hyperplasia
characterized by increased numbers of myeloid cells in the spleen,
which was accompanied by a block in early BM B cell
development. Although, both N1N2K5 and RBP-JK5 mice
develop a MPD, this was not observed in K14-TSLP tg mice or
in the grafted athymic nu/nu mice which had 10-50x lower TSLP
serum levels, suggesting that TSLP can only induce a MPD, when
present at high concentrations. Thus, our studies provide the first
genetic proof that high TSLP concentrations are causative for the
development of a cell non-autonomous MPD. The nature of the
hematological disorder is dependent on the age of the mice
(embryonic versus adult) while the development of the MPD
appears to depend on the TSLP concentration. TSLP serum levels
have not been studied in AD patients. As they are known to have
an increased risk of developing hematopoietic malignancies
correlating with the severity of their dermatitis [27,28,29], we
analyzed serum from AD patients and found 2 out of 4 patients
had increased TSLP levels (50 and 57 pg/ml compared to
undetectable levels in all controls). Thus it will be interesting in
future studies to correlate patient TSLP serum levels with the risk
of developing hematological malignancies.
In conclusion, our studies reveal novel aspects of Notch
signaling in adult versus embryonic skin; it is essential to control
local and systemic inflammatory responses. Loss of Notch signaling
in the embryonic skin leads to a cell non-autonomous B-cell
lymphoproliferative disease as previously reported [13]. However,
Notch inactivation in the adult skin does not cause B-LPD; instead
it causes an AD-like disease accompanied by a cell non-
autonomous G-CSF induced MPD and osteopenia. Our genetic
studies reveal that TSLP receptor mediated signaling is causative
for the different hematological disorders (Figure 7).
Materials and Methods
Mice
Notch1lox/lox [68], Notch2lox/lox, Notch1lox/lox Notch2lox/lox [17] and
RBP-Jlox/lox [18] mice were crossed with K5CreERT [19] transgenic
mice. TSLPR2/2 [30] mice were crossed to N1N2K5 mice to
generate N1N2K5 TSLPR2/2 mice. G-CSF-/- mice [69] were
crossed to RBP-JK5 mice to generate RBP-JK5/G-CSF+/2 mice.
For gene inactivation 8-day-old control and floxed Notch mutant
mice were injected with 1mg/20g body weight of tamoxifen
(Sigma-Aldrich, Switzerland) for 5 consecutive days. K14-TSLP
transgenic, IL-7Ra2/2 [70] and Msx2Cre mice were previously
described [7,71]. Athymic (Swiss nu/nu, inbred) mice used for the
transplantation experiments were purchased from Iffa Credo-
Charles River (France).
Ethics Statement
All animal work was conducted according to Swiss national
guidelines. All mice were kept in the animal facility under EPFL
animal care regulations. They were housed in individual cages at
2361uC with a 12-h light /dark cycle. All animals were supplied
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with food and water ad libitum. This study has been reviewed and
approved by the Service Ve´te´rinaire Cantonal of Etat de Vaud.
Flow Cytometry and Cell Sorting
Single-cell suspensions of BM were prepared and stained
following standard protocols for fluorescence-activated cell-sorter
scanner (FACS) analysis using the following monoclonal antibody
conjugates: CD43-FITC (clone S7, BD Pharmingen), Gr-1-PE-
Cy7 (clone RB5-8C5, ebiosciences); B220 (RA3.6B2)–Alexa Fluor
647; CD11b (M1/70)-Alexa Fluor 647 and CD45.2 (104)–PE. All
antibodies were purified from hybridoma supernatants and
conjugated in our laboratory according to standard protocols.
Alexa Fluor 647 conjugates were prepared using the appropriate
Alexa Fluor protein labeling kits (Invitrogen). PE conjugates were
prepared using kits purchased from Prozyme. Single-cell suspen-
sions were stained with the respective antibodies and analyzed
using a FACSCalibur, FACSCanto (Becton Dickinson) or CyAn
flow cytometer (Dako). Dead cells and debris were eliminated by
appropriate gating on forward and side scatter. The data were
analyzed using FlowJo (TreeStar, Inc.) software. EPLMs were
stained and sorted on a FACSAria flow cytometer (Becton
Dickinson) as previously described (Balciunaite et al., 2005).
Sorted EPLMs were culture on irradiated (3000 rads) ST2 stromal
cells in the presence of recombinant murine TSLP (555-TS-010,
R&S Systems).
Quantitative RT-PCR
Keratinocytes were scraped from frozen skin of control or
N1N2K5 and RBP-JK5 mice and total RNA was isolated using
TRIZOL reagent (Invitrogen). RNA was quantified using a ND-
100 NanoDrop spectrophotometer (NanoDrop Technologies).
1 mg of total RNA was reverse-transcribed using the Quantitect
reverse transcription kit (Qiagen). 18S was used to control for
equal cDNA inputs. Real-time PCR was conducted with a
LightCycler system (Roche Diagnostics). Reactions were per-
formed using primers and template mixed with the LightCycle
DNA master SYBR Green kit and run for 45 cycles. Specificity of
the reactions was determined by subsequent melting curve
analysis. LightCycler analysis software was used for quantifica-
tions, and background fluorescence was removed using the noise
band. The number of cycles needed to reach the crossing point for
each sample was used to calculate the amount of each product
using the 2-DDCP method. Relative levels of expression were
normalized to 18S or HPRT expression.
PanNotch Staining
Paraffin embedded skin samples were sectioned at 4 mm. The
sections were dewaxed and antigen retrieval was performed in
trisodium citrate solution at 95uC for 209. Sections were blocked in
1% BSA in TBS-Tween for 45 minutes. 20 mg/ml of Delta4-IgG
fusion protein [17] or of human IgG (Caltag #12400C) was then
added and the slides were hybridized over night at 4uC. The
sections were then stained with an Alexa FluorH 568 conjugated
goat anti-human IgG (H+L) diluted at 1 in 500 (Invitrogen/
Molecular Probes #A-21090) for 1h at room temperature. Nuclei
were stained with DAPI (D-9542, Sigma). The sections were
mounted with DABCO (D-2522, Sigma). Photos were taken with
an Axioplan microscope with an Apotome (Zeiss).
Additional experimental procedures can be found online as
supporting information (Data S1).
Figure 7. Model for the role of Notch signaling in adult skin and how its loss results in the development of AD, MPD and oteopenia.
Notch receptors are expressed in the suprabasal cell layer of the skin. Skin specific loss of Notch signaling leads to pronounced secretion of TSLP by
epithelial cells. High TSLP serum levels in the embryo or neonates cause a cell non-autonomous B-LPD. In contrast, the presence of TSLP in adult mice
results in the recruitment of mast cells and eosinophiles within the dermis of Notch mutant mice, thereby contributing to massive inflammation and
the development of an AD-like disease. At very high TSLP serum levels, G-CSF is produced by a currently unknown cell type, causing the cell non-
autonomous development of MPD and osteopenia.
doi:10.1371/journal.pone.0009258.g007
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Supporting Information
Data S1 Supplementary Experimental Procedures
Found at: doi:10.1371/journal.pone.0009258.s001 (0.04 MB
DOC)
Figure S1 Loss of both Notch1 and Notch2, or RBP-J, but not
Notch1 or Notch2 alone, leads to the development of a severe skin
phenotype. Representative HE staining, Keratin14 (K14), Kera-
tin1 (K1), Loricrin (Lori) and Ki67 immunohistochemistry and
Toluidine Blue (TB) staining on dorsal skin sections from control
(Ctrl), N1K5, N2K5, N1N2K5 and RBP-JK5 mice (all within 30-
40 days of tamoxifen injection) (n = 8, from 4 individual
experiments). Mice lacking Notch2 in the epidermis are indistin-
guishable from controls, whereas Notch1 deficient mice show K14
expression throughout the epidermis (whereas it is confined to the
basal layer in controls), have a hyperproliferative epidermis and a
mild increase in toluidine blue positive mast cells. Loss of Notch
signaling in N1N2K5 or RBP-JK5 mice leads to an even more
hyperproliferative phenotype with Ki67 positive cells throughout
the entire epidermis, which is also K14 positive. However, K1 and
Loricrin are still expressed in the upper layers of the epidermis.
Loss of Notch signaling also leads to a massive dermal infiltration
of mast cells [Scale bars: 50 mm].
Found at: doi:10.1371/journal.pone.0009258.s002 (4.69 MB TIF)
Figure S2 Analysis of DCs and other bone marrow derived cells
in the skin. (A). Histograms show the staining of CD45 in total
dermal cell suspensions from control (Ctrl) or N1N2K5 mice. The
percentage of CD45+ cells is indicated. The bar diagram indicates
the percentage of T cells (CD3+ cells), B cells (CD19+ cells),
dendritic cells (DCs, CD11b+ CD11c+ cells), neutrophils (Ly6G+
cells) and other myeloid cells (CD11b+ CD11c-) within the CD45+
gate in control (Ctrl) or N1N2K5 dermis. Dot plots show analysis
of DCs (gated as CD45+ CD11c+) populations in the dermis.
CD11b versus CD103 staining displays an increase of dermal
Langerin+ DCs (CD11b+ CD103+) in N1N2K5 mice (41.2%)
compared to control (Ctrl) mice (21.3%). CD11b versus Ly6C
staining shows an increase of inflammatory DCs (CD11b+ LyC+)
in N1N2K5 dermis (53.5%) compared to Ctrl dermis (7.5%).
Plasmacytoid DCs (CD11b- CD11c+ PDCA1+) were not detected
either in control (Ctrl) or N1N2K5 dermis (data not shown). Prior
to flow cytometric analysis the CD45 population as well as the
populations of DCs were enriched using magnetic MACS cell
separation. (B) Histograms show CD45 staining in total epidermal
cell suspensions from control (Ctrl) and N1N2K5 mice. The
percentage of CD45+ cells is indicated. The bar diagram indicates
the relative percentage of murine dendritic epidermal T cells
(DETCs, CD3+ Vc3+), Langerhans cells (LCs, CD11b+ CD11c+),
and CD11b+ CD11c- cells within the CD45+ gate in control and
N1N2K5 epidermis. Flow cytometric analysis was performed after
magnetic MACS cell enrichment. Cells analyzed were a pooled
sample size of n = 8 for control or n= 8 for N1N2K5 from two
individual experiments.
Found at: doi:10.1371/journal.pone.0009258.s003 (0.83 MB TIF)
Figure S3 Quantitative RT-PCR on dermis-derived RNA for
the T helper specific cytokines IFNc, IL-12, IL-13, IL-17a, IL-21,
IL-22 from Ctrl and N1N2K5 mice. Two to four individual
experiments were performed (n= 3 per sample group); each
experiment was run in triplicates (* p,0.01).
Found at: doi:10.1371/journal.pone.0009258.s004 (0.19 MB TIF)
Figure S4 Skin-specific transgenic TSLP expression is sufficient
to induce a similar AD phenotype as the Notch signaling deficient
mice. Representative HE staining, Ki67 immunohistochemistry
and Toluidine Blue (TB) staining on skin sections from control
(Ctrl, n = 4), N1N2K5 (n = 8) and K14-TSLP mice (n = 4). The
results shown are representative of 2 individual experiments. Both
N1N2K5 and K14-TSLP mice show acanthosis, hyperkeratosis as
well as dermal infiltration by mast cells [Scale bars: 50 mm].
Found at: doi:10.1371/journal.pone.0009258.s005 (8.68 MB TIF)
Figure S5 Loss of TSLP signaling or reduction of GCSF levels
rescues the MPD. (A) Absolute cell numbers in the spleen of
control, N1N2K5, N1N2K5 TSLPR2/2, RPB-JK5 and RBP-
JK5/GCSF+/2 mice. (B) Splenic absolute cell numbers of
immature (CD11b+Gr.1lo/int) and mature (CD11b+Gr.1lo/
int) myeloid populations, as well as (C) marginal zone
(B220+CD21+CD23lo) and follicular (B220+CD21intCD23+) B
cells. (n = 5 per sample group from two individual experiments).
Found at: doi:10.1371/journal.pone.0009258.s006 (0.42 MB TIF)
Figure S6 The MPD in mice lacking Notch signaling in the
epidermis is cell non-autonomous. (A) Representative flow
cytometric analysis of chimeras (WT CD45.1+ BM cells derived
from n= 3 mice were transplanted into 9 lethally irradiated RBP-
JK5 mice). WT cells adopt a similar myeloproliferative phenotype
in the BM and spleen as in the RBP-JK5 mice. (B) Representative
flow cytometric analysis of reverse chimeras (CD45.2+ BM cells
derived from 3 sick RBP-JK5 mice were intravenously transplant-
ed into 9 lethally irradiated WT CD45.1+ recipients). RBP-JK5
derived BM cells show normal hematopoiesis in a WT
environment. The results in A and B are derived from 3 individual
experiments.
Found at: doi:10.1371/journal.pone.0009258.s007 (2.40 MB TIF)
Figure S7 Loss of Notch signaling in the epidermis leads to
osteopenia and is due to high G-CSF levels. (A) Representative X-
ray analysis of femurs from control (Ctrl) and N1N2K5 mice
showing a marked decrease in bone density in the mutant bone.
(B) Femur length of control (Ctrl) and N1N2K5 mice (* = p
value,0.05, n = 10, three individual experiments). (C) Femur
cortical thickness of control (Ctrl) and N1N2K5 mice (* = p
value,0.001, n= 10, three individual experiments). (D) Repre-
sentative HE staining on femoral bone sections from control (Ctrl),
N1N2K5, RBP-JK5 and RBP-JK5/G-CSF+/2 mice showing a
loss of endosteal cells in N1N2K5 and RBP JK5 mice and rescue
of this phenotype in the RBP-JK5/G-CSF+/2 mice (n = 5 per
sample group, two individual experiments). [Scale bars: 50 mm].
Found at: doi:10.1371/journal.pone.0009258.s008 (3.62 MB TIF)
Figure S8 Intact stratum corneum in N1N2K5 mice. Down
regulation or loss of LEKTI is frequently observed in skin with
altered desquamation, impaired keratinization and skin barrier
defects. LEKTI deficiency causes abnormal desmosome cleavage
in the upper granular layer through degradation of desmoglein 1.
This leads to defective stratum corneum adhesion and thus to the
loss of barrier function. Positive staining for (A) the multi-domain
serine protease inhibitor LEKTI (lympho epithelial kazal-type
inhibitor) and (B) Desmoglein indicates the presence of an intact
epidermis in both control (Ctrl) and N1N2K5 mice 5 weeks after
gene inactivation (n= 3 mice per sample group, two individual
experiments). [Scale bars: 50 mm].
Found at: doi:10.1371/journal.pone.0009258.s009 (5.28 MB TIF)
Figure S9 TSLP is required for B-LPD occurrence in Notch
signaling-deficient animals. TSLP binds to a heterodimeric
receptor that shares one of its subunits (IL-7ra) with IL-7 receptor.
Inhibiting TSLP effects by removing either TSLPR (TSLPR2/2)
or IL-7ra (IL7ra2/2) subunit of TSLP receptor leads to
disappearance of B-LPD in the mutant mice. (A) WBC counts of
RBP-j-deficient animals lacking IL-7ra (Msx2-Cre/+; RBP-jflox/
flox; IL-7ra2/2 or RBP-jCKO;IL7ra2/2) are within the
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normal range at P14. (B) Flow cytometric analysis on peripheral
blood shows no signs of B-LPD in RBP-jCKO;IL7ra2/2 mice
compared to their Msx2-Cre/+; RBP-jflox/flox; IL-7Ra+/2
(RBP-jCKO) littermates at P14. Representative results are shown
with B220+ B cell percentage (red) in the upper right corner of
each dot plot. IL-7ra2/2 and wild type littermates are also
analyzed as controls. Note that WBC counts and B cell percentage
of RBP-jCKO;IL7ra2/2 and IL-7ra2/2 mice are lower than
wild-type (IL-7ra+/2) littermates. This may be due to a
simultaneous inhibition of IL-7 reception and reduction in baseline
B and T cells especially in adulthood. (C) WBC counts of
N1N2CKO animals lacking IL-7ra (Msx2-Cre/+; Notch1flox/
flox; Notch2flox/flox; IL-7ra2/2 or N1N2CKO;IL7ra2/2) are
normal at P14. (D) Similar normalization of WBC counts is seen
with PSDCKO animals that have lost the TSLPR arm of TSLP
receptor (Msx2-Cre/+; PS1flox/flox; PS2flox/flox; TSLPR2/2
or PSDCKO;TSLPR2/2). (E, F) B-LPD prevention leads to
increased life span among (E) N1N2CKO;IL7ra2/2 and (F)
PSDCKO;TSLPR2/2 animals compared to their N1N2CKO
and PSDCKO littermates respectively (p,0.001, log rank test). In
each panel, data are compiled from 4 animals in each group from
two individual experiments.
Found at: doi:10.1371/journal.pone.0009258.s010 (1.75 MB TIF)
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